Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zonisamide-induced weight reduction versus CPAP in obstructive sleep apnea
2009-015859-24Phase 2Terminated
- Sponsor
- University of Gothenburg
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of zonisamide in obstructive sleep apnea hypopnea syndrome (OSAHS) (4 arms), sponsored by University of Gothenburg. Primary endpoint: Apnea alleviation after zonisamide or CPAP. Started Oct 2009; status: terminated.
02
Drugs
zonisamide
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on 2009-015859-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015859-24.